Document is current
Any future updates will be listed below
-
Authors
Saavedra, Alene A.
Mueller, Kevin T.
Kowalski, Emily N.
Qian, Grace
Bade, Katarina J.
Vanni, Kathleen M. M.
McDermott, Gregory C.
Sparks, Jeffrey A.
-
Funding
Funding for this research was provided by:
Rheumatology Research Foundation Scientist Development Award
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR080659)
National Heart, Lung, and Blood Institutes (R01 HL155522)
R. Bruce and Joan M. Mickey Research Scholar Fund
Llura Gund Award
- License Information
-
More Information
Article History
Accepted: 4 September 2024
First Online: 16 September 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Sparks has received research support from Boehringer Ingelheim, Bristol Myers Squibb, Janssen, and Sonoma Biotherapeutics unrelated to this work. He has performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Merck, MustangBio, Optum, Pfizer, ReCor, Sana, Sobi, and UCB unrelated to this work. The funders had no role in the decision to publish or preparation of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. All other authors report no conflicts of interest.
